Advertisement
Advertisement
U.S. markets open in 40 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Owens & Minor, Inc. (OMI)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
35.24+2.04 (+6.14%)
At close: 4:00PM EDT
Advertisement
Sign in to post a message.
  • Y
    Yahoo Finance Insights
    Owens & Minor is up 4.91% to 34.83
  • N
    Not sure
    Am I missing something? They completely crushed their numbers compared to where they were last year for the same period (Q2) and the stock is down over 12% today.
  • S
    Sam
    Typical short action..Shorties should be banned from Wall Street trading.. .They are undermining the very concept of stock trading.....
  • Y
    Yahoo Finance Insights
    Owens & Minor is up 4.94% to 34.21
  • A
    A_Train
    I see 30-40% short term runway and possibility for much more. Company is way too undervalued in comparison to peers and PPE increase usage is here to stay in the health care industry. Company is definitely on the right track under Pesicka.
    Bullish
  • A
    A_Train
    Am hearing chatter in the supply chains that Halyard, an Owens and Minor Company, is preparing and ready to assist the U.S. and other countries with recent concerns over the spread of the Coronavirus. Halyard is the #1 U.S. manufacturer and provider of facial protection, face masks, N95 Respirators, gowns and other infectious control supplies; all made in the USA! They are able to supply customers in a much shorter time frame than competitors who have extra-long lead times from overseas manufacturers. Owens and Minor and Halyard will be there to keep our Healthcare providers and citizens safe; let’s keep building momentum!
    Bullish
  • A
    A_Train
    Nice momentum leading up to earnings where I am hoping to get objective data on how much PPE was sold in the first quarter, guidance moving forward, and information on new long term supply business that was won recently; am still extremely bullish on OMI and looking for big breakout soon.
    Bullish
  • O
    Omi-Wan
    $APT conversation
    $APT $OMI

    Why PPE Stocks....

    - 5000% increase in demand for the products.
    - All you hear every day on the news is about the shortage of PPE (personal protective equipment)
    - Most businesses have closed, but PPE companies will continue to be essential as this virus spreads across the nation and the world.
    - PPE companies are ramping up shifts and running 24 hours now.
    - PPE companies are putting expansion efforts in place in the next few months to exponentially grow production.
    - At some point once we have enough PPE for our medical professionals, we will most likely follow suit with other countries that have been able to flatten the curve by having all citizens wear n95 masks.
    - When we finally get past this world wide disaster, we will need these PPE companies to continue to mass produce the PPE in case there is another wave of the virus, and also create future emergency stock piles in case of future pandemics.

    Thoughts?
    Bullish
  • A
    A_Train
    Bulls, these swings are very tough to go through, but this stock has always been manipulated by the shorts because of the small amount of retail ownership. 90%+ is owned by major institutions, and I have experienced many swings like this over the last 12 months owning this stock. At this point, if you are long, the best choice is to hold on until earnings when we will get some future guidance from management and see what the true effect of the virus demand is. Hopefully they will get some analyst upgrades after and the stock price will reflect. If you are short, have fun while this lasts, but I caution betting against a company that is likely to blow away revenue projections and likely win some new long term contracts. The debt has been there and the company has been paying down significantly before Covid19, and now will pay down even faster. I am willing to stay in and see the next card, and am still extremely bullish.
    Bullish
  • m
    malcolm
    The short term negative short term case on OMI has been that non elective surgery sale declines will offset PPE gains. Several states including Ohio have reopened hospitals for those procedures.Therefore, by the end of Q2 any increased PPE sales will become additive to the base revenue levels. No word that I have seen from AGM. Next short term data point will be APT earnings on Monday(?), to be followed by OMI. Chart still looks good, but theses pullbacks are scary.
  • A
    A_Train
    Ed Pesicka did an amazing job on Mad Money. Finally the company is getting some national coverage, and showcased that much of their manufacturing takes place right here in the U.S.A. @Michael keeps dogging the company, but can't accept the fact that this stock was vastly undervalued, and that this new C.E.O. came in to create a "turnaround", and this is what good CEOs do in a turnaround. He comes from Thermo Fisher, a $100+ bil company, and left that company because he saw a huge opportunity in OMI. OMI has all the pieces; manufacturing, distribution to the hospital and the home, technology, and services. Pesicka needs to keep the pressure on, and do as much as he can to attract coverage, just as he did today. Off to the races from here. Kudos to the OMI team for making this happen.
    Bullish
  • S
    Sandra
    OMI has not sold this low since 2004. Now selling below book value. Medical supply field expected to do well in 2018. The downtrend seems overdone. Dividend looks fairly safe to us. Investors buying at this level should make a decent profit. Good luck if you've holding.
  • A
    A_Train
    Still great opportunity to get in, this thing should move towards $20+ by next earnings and $25-$30 into next year. Company is poised for very solid sustained growth.
    Bullish
  • A
    AndrewJ5267
    CFRA MAINTAINS BUY OPINION ON SHARES OF OWENS & MINOR INC.
    3:16 pm ET March 31, 2020 (CFRA) Print
    We lift our target price by $2 to $11, 16.1x our 2021 EPS, slightly below OMI's current NTM forward P/E of 17.0x. We expect the recent rally in the stock to continue after 2020 EPS guidance reaffirmation and the CEO's comments on rapidly increasing personal protective equipment demand during the Covid-19 crisis. Following yesterday's record daily jump in the stock price (+52%) we are seeing another low-teens increase today, with the stock nearing $9.50 levels. Post Q4 earnings, we lifted our 2020 EPS estimate by $0.05 to $0.55, which stands at the middle of the reaffirmed guidance range, as we anticipated improved earnings in the first half of 2020 thanks to higher PPE sales due to Covid-19. We reiterate our view that despite high leverage (Net Debt/EBITDA at 6.4x as of December 31, 2019), the company is one of the best positioned health care distributors in our coverage universe during the Covid-19, crisis with its distinctive advantage of having its manufacturing facilities mainly in the Americas.
  • A
    A_Train
    Looks like the fed is going to be stepping up purchases of masks, gloves, and gowns. OMI/Halyard is one of the only U.S. manufacturers who can do all three. 3m just does masks, and both Cardinal and Medline have most of their manufacturing in China (and I believe much in Wuhan!). This could be much more than just a boost in sales for the first quarter, and this 138 year-old American company is well positioned to gain back some market share and help the U.S. in this battle. We will hear from Pesicka and his team this week for the earnings call. I am looking for some forward guidance from them. Let's keep the momentum going this week!
    Bullish
  • S
    Sherry
    Today's move--announced that Medline was to be acquired by a group of private equity firms for $30B. Medline, privately held, reportedly has sales of ~$17B and is the largest manufacturer and distributor of med equip and supplies in the US. Don't have any info or profitability but believe that it does more manufacturing than OMI and should have much better margins. Strictly for what it is worth--which ain't much--the sale price works out to about 1.75 times sales. A similar metric for OMI would get to a share price in the vicinity of $200 per share. The math is simple but it would silly to buy the stock with this as a target.
  • A
    AndrewJ5267
    Any news related to the stock price jump?
  • A
    A_Train
    Expecting to see a blowout on their first quarter numbers in a few weeks, and likely adjusted upward guidance for the following quarters. Covid19 acted as a trampoline to get OMI to the destination Ed Pesicka and team were already working on before the pandemic hit, it will now just be a lot faster than we originally thought. Extremely bullish here, and we should see a spike after earnings. Day traders will make money on the swings, but for longer term investors, I see this a 12-18 month hold before the stock reaches its true potential.
    Bullish
  • M
    Martin
    Wondering how OMI can pay $700 million for Halyard's S&IP business, and less than a year later have a market cap of $215 milion. Now, how does that work?
  • M
    Mordena Vs Vanilla Ice
    Fact Check: This is no bio tech company approved by FDA. Unusual surge of temporary Covid related temp job service. No one without substance abuse problem will buy after 81% single day rally after the news. Only relevant factor is it has had large short position. Anyone still hasn't covered won't cover. A few robinhood shorts will cover tomorrow but that is not substantial enough to move the price. Short squeeze is done deal. I took short position today avg around $14.5 I won't cover until Friday or so unless it dips below $12
Advertisement
Advertisement